美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

HORIZON KINETICS MEDICAL ETF

35.29

+0.33190.95%

盘后：35.300.0109+0.03%16:10 EDT

成交量：227

成交额：8,052

市值：1,658.40万

市盈率：- -

高：35.30

开：35.30

低：35.29

收：34.96

52周最高：37.90

52周最低：28.87

股本：46.99万

流通股本：46.99万

量比：0.09

换手率：0.05%

股息：0.41

股息率：1.16%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

ETF日报：短期看在A股整体市场动能偏弱、热点轮动加快的环境下，前期调整的创新药、CXO板块拥有一定性价比

佰仁医疗：主动脉根部扩大补片进入特别审查程序，≤23mm

全球首个脑机接口医疗器械标准落地！国内产业迈入规范化黄金期

康哲药业(00867)：创新药高选择性TYK2抑制剂CMS-D001 获得系统性红斑狼疮适应症药物临床试验批准通知书

恒瑞创新药凝血因子XI单抗SHR-2004注射液用于择期膝关节置换手术后成年患者静脉血栓预防的上市申请获受理

白云山：超10个创新药管线引进项目已完成立项

康泰医学：获得两项医疗器械注册证

ETF日报(09.14)丨WCLC临床数据密集兑现，创新药板块震荡回升算力需求预期遭重估

强生骨科业务引阿波罗兴趣，潜在200亿美元交易推动盘前股价上涨1.2%

强生股价盘前上涨1.2%，此前有报道称阿波罗全球管理公司有意收购强生旗下骨科业务，潜在交易估值约为200亿美元。

ETF异动 | 华夏恒生生科(03069)涨超4% WCLC临床数据催化密集机构看好创新药投资机会

【券商聚焦】华创证券维持翰森制药（03692）推荐评级指创新药驱动业绩增长

A股收评：创业板指震荡走低跌1.1%，培育钻石、创新药、MLCC概念板块涨幅居前

乐高科技、艾迪尔等35家药企涉商业贿赂，登上贵州医保基金失信企业“黑榜”

创新药闯关医保

国际金融报

港股异动 | 创新药概念股全线走高 WCLC临床数据重磅催化机构指回调后配置价值凸显

蚂蚁集团入股医疗服务商风石健康

“超30家药企长期行贿”，涉案医院回应

A股午评：沪指低开高走涨0.16%，MLCC概念、创新药、培育钻石板块表现活跃

医疗服务板块走高，万邦医药20cm涨停

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/MEDX/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":35.2891,"timestamp":1789416000000,"preClose":34.9572,"halted":0,"volume":227,"hourTrading":{"tag":"盘后","latestPrice":35.3,"preClose":35.2891,"latestTime":"16:10 EDT","volume":7,"amount":247.0237,"timestamp":1789416603919,"change":0.0109,"changeRate":0.000309,"amplitude":0},"delay":0,"changeRate":0.009494467520281871,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"已收盘","change":0.3319,"latestTime":"09-14 16:00:00 EDT","open":35.3,"high":35.3,"low":35.2891,"amount":8052,"amplitude":0.000312,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9572,"sharesOutstanding":569946,"nav":34.94,"aum":16419913.24,"dividendRate":0.01159,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.3,"preClose":35.2891,"latestTime":"16:10 EDT","volume":7,"amount":247.0237,"timestamp":1789416603919,"change":0.0109,"changeRate":0.000309,"amplitude":0},"volumeRatio":0.087916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.087916,"shares":469946,"dividePrice":0.409,"high":35.3,"amplitude":0.000312,"preClose":34.9572,"low":35.2891,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":35.2891,"eps":0,"divideRate":0.01159,"volume":227,"delay":0,"ttmEps":0,"open":35.3,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":36.6906,"twentyDayClose":35.6938,"sixtyDayClose":34.2263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667685646","title":"ETF日报：短期看在A股整体市场动能偏弱、热点轮动加快的环境下，前期调整的创新药、CXO板块拥有一定性价比","url":"https://stock-news.laohu8.com/highlight/detail?id=2667685646","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667685646?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 19:02","pubTimestamp":1789383720,"startTime":"0","endTime":"0","summary":"形成赛道级利好共振，重塑市场对创新药研发进度与商业化价值的预期，修复创新药β行情，抬升CXO产业链订单与研发景气度预期。前期创新药、CXO板块经历持续回调，整体估值与市场情绪充分降温，板块点位回落至6-8月宽幅震荡箱体下沿位置，具备一定的技术性反弹空间。展望后市，短期看，在A股整体市场动能偏弱、热点轮动加快、反弹逐步收敛的环境下，前期调整的创新药、CXO板块拥有一定性价比。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-14/doc-iniruxuw4057482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07233","IBBQ","83188","WX","BK1147","159982","LNGR","02846","159992","BK1161","03188","FDN","MEDX","82846","BK4585","83130","399300","BK4550","06978","CXO","03130","BK1574","02827","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667765011","title":"佰仁医疗：主动脉根部扩大补片进入特别审查程序，≤23mm","url":"https://stock-news.laohu8.com/highlight/detail?id=2667765011","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667765011?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 18:54","pubTimestamp":1789383247,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","IEIH","MEDX","LNGR","PTH","MDEV","LGHT","RSPH","GDOC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668562","title":"全球首个脑机接口医疗器械标准落地！国内产业迈入规范化黄金期","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668562","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668562?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 18:50","pubTimestamp":1789383002,"startTime":"0","endTime":"0","summary":"9月14日，国家药监局批准发布我国第三个脑机接口医疗器械标准，也是全球第一个采用人工智能技术处理脑电数据的脑机接口医疗器械产品标准，新标准将于明年9月1日起正式实施。业内人士表示，国家药监局采用快速程序立项和标准，新标准为脑机接口医疗器械的研发生产提供了统一的脑电数据集的“质量标尺”，达到国际领先水平。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/14/20260914306536.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/14/20260914306536.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260914/32369354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["DUST","FAAR","MGCmain","JNUG","PICK","IAUI","SHNY","BEGS","GDX","USG","GDOC","GDXJ","GDXU","GDXY","IAU","GCmain","GOLY","GLL","XME","GDXD","AAAU","1OZmain","GLTR","PALL","02840","HART","UYM","CEF","159883","DZZ","LGHT","GBUG","PHYS","GOAU","IAUM","MEDX","OUNZ","MDEV","SGOL","09996","RSPH","159831","BAR","IBRN","PTH","UGL","IEIH","AGNG","GLDM","DULL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657414","title":"康哲药业(00867)：创新药高选择性TYK2抑制剂CMS-D001 获得系统性红斑狼疮适应症药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657414","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657414?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 18:23","pubTimestamp":1789381419,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 公布，于2026年9月11日，创新药CMS-D001片获得中国国家药品监督管理局签发的药物临床试验批准通知书，于2026年9月14日收到药物临床试验批准通知书。NMPA同意集团开展临床试验以评价CMS-D001治疗系统性红斑狼疮适应症的有效性和安全性。CMS-D001作为高选择性TYK2抑制剂，相较于泛JAK抑制剂，CMS-D001对其他JAK家族激酶的影响较小，可在长期疾病控制中维持疗效并降低相关安全风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LNGR","SG9999015986.USD","SG9999015978.USD","LU2488822045.USD","159992","SG9999015945.SGD","BK1574","IE00BYV24P56.USD","MDTX","SG9999004220.SGD","MEDX","IE00BMCWC346.EUR","IBBQ","BK1593","IBBJ","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","IE00BGHQDM52.EUR","PSYK","BK1161","SG9999015952.SGD","00867","SG9999004311.SGD","BMED","BK1191","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667657738","title":"恒瑞创新药凝血因子XI单抗SHR-2004注射液用于择期膝关节置换手术后成年患者静脉血栓预防的上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667657738","media":"恒瑞医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667657738?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 17:59","pubTimestamp":1789379940,"startTime":"0","endTime":"0","summary":"近日，恒瑞医药子公司北京盛迪医药有限公司收到国家药监局下发的《受理通知书》，公司1类创新药、凝血因子XI单克隆抗体SHR-2004注射液的药品上市许可申请获受理，拟定适应症为：用于择期膝关节置换手术的成年患者，以预防静脉血栓形成。该研究旨在评价行择期TKA的患者使用SHR-2004注射液预防静脉血栓栓塞症的有效性和安全性。此外，SHR-2004用于卵巢癌术后VTE预防的Ⅱ期试验已完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-14/doc-iniruxuy4531842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","BK1574","IPOS","MEDX","LNGR","BK1161","159992","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667654298","title":"白云山：超10个创新药管线引进项目已完成立项","url":"https://stock-news.laohu8.com/highlight/detail?id=2667654298","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667654298?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 17:36","pubTimestamp":1789378605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","IBBQ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659094","title":"康泰医学：获得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659094?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 16:44","pubTimestamp":1789375491,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","IEIH","MEDX","PTH","LNGR","GDOC","RSPH","LGHT","AGNG","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667582651","title":"ETF日报(09.14)丨WCLC临床数据密集兑现，创新药板块震荡回升 算力需求预期遭重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2667582651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667582651?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 16:44","pubTimestamp":1789375451,"startTime":"0","endTime":"0","summary":"WCLC临床数据密集兑现，创新药板块震荡回升；AI巨头集体\"喊停\"，算力需求预期遭重估，通信板块多数走低。行业表现WCLC临床数据密集兑现，国内外投行相继看好中国CRO/CDMO复苏明确，创新药板块震荡回升。消息面上，9月12日至15日，2026年世界肺癌大会在韩国首尔举行，多项国产创新药临床数据集中亮相，中国新药入选口头报告19项、小型口头报告45项，双双刷新历史纪录，肺癌领域ADC与双抗数据成为焦点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4550","AIQD","BK4585","BK4588","159992","FDN","MEDX","BK1161","AIVC","BK1574","LNGR","IBBQ","BAI","EPAI","06978","AIQU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171745492","title":"强生骨科业务引阿波罗兴趣，潜在200亿美元交易推动盘前股价上涨1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171745492","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171745492?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 16:18","pubTimestamp":1789373891,"startTime":"0","endTime":"0","summary":"据报道，强生公司的骨科业务部门吸引了阿波罗全球管理的关注，这一潜在交易估值或达200亿美元。受此消息提振，强生股价在盘前交易中上涨了1.2%。知情人士透露，私募股权巨头阿波罗已就收购强生骨科业务的可能性进行了初步接触。强生骨科业务涵盖创伤修复、关节置换、脊柱外科及运动医学等多个细分领域，在全球范围内拥有广泛的市场布局。截至发稿时，强生和阿波罗均未对此传闻发表官方评论。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0889566641.SGD","SG9999002224.SGD","IE00BGHQF631.EUR","IE00BFTCPJ56.SGD","IE00BDGV0183.EUR","IE00B7SZLL34.SGD","LU0006061336.USD","IE00BLSP4452.SGD","BK4568","IE0001KFT4U8.USD","LU2430703095.HKD","SG9999002232.USD","LU1221951046.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU0545562505.USD","LU0072461881.USD","SG9999001176.SGD","IE000MB6IJN5.SGD","LU0345770308.USD","LU1430594728.SGD","LU2750360641.GBP","LU2487616109.SGD","IE00B3PB1722.GBP","LU2129689605.HKD","IHE","LU1228905540.USD","LU0053666078.USD","LU0289739699.SGD","IE0002141913.USD","LU1496350502.SGD","FTXH","LU0098860793.USD","LU1732800096.USD","LU1228905037.USD","LU2756315318.SGD","LU1043141123.HKD","LU1674673691.USD","LU2430703178.SGD","LU0057025933.USD","IE00B19Z3B42.SGD","IE00BN8TJ469.HKD","LU0162691827.USD","LU1074936037.SGD","LU0472753341.HKD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","LU0683600562.USD","LU1221951129.SGD","LU0820562030.AUD","LU1280957306.USD","LU2133065610.SGD","LU2592432038.USD","BK4592","LU1551013342.USD","LU0289739343.SGD","LU1032955483.USD","LU2023250330.USD","IXJ","LU0210528500.USD","LU1057294990.SGD","LU1674673428.USD","BK4581","BK4534","IE000SO60NU8.SGD","BK4504","IE000BZT7R73.USD","IE00B3T34201.USD","LU0114720955.EUR","LU1718418525.SGD","RXL","LU1043141396.HKD","LU1244550494.USD","LU2471134796.USD","IE00BVYPNW00.USD","LU2129689431.USD","IE000M9KFDE8.USD","LU0070217475.USD","LU1989771016.USD","LU2602419157.SGD","LU0689626769.HKD","SGXZ57979304.SGD","IE0009355771.USD","LU0882574055.USD","PRVT","LU0106831901.USD","LU1066051811.HKD","LU1585245621.USD","IE000F7OJYX1.SGD","IE00BZ1G4Q59.USD","APO","LU0466842654.USD","LU0426417589.USD","LU1323610961.USD","LU0234572021.USD","IE00B42XCP33.USD","LU2750360997.AUD","LU0792757196.USD","BK4532","LU1059921491.USD","JDOC","LU1032466523.USD","LU1929549753.HKD","LU1894683264.USD","LU2471134879.HKD","LU0320765646.SGD","LU0345769128.USD","LU0795875169.SGD","LU1791807156.HKD","LU1261432733.SGD","LU0069063385.USD","LU0289961442.SGD","IE00B3S45H60.SGD","BK4007","SG9999013999.USD","LU0820561909.HKD","LU0122379950.USD","LU1162221912.USD","IE00BLSP4239.USD","IE0034235303.USD","LU1935042991.SGD","LU0943347566.SGD","IE00B775SV38.USD","LU1244550221.USD","LU2756315664.SGD","BK4135","BK4588","IYH","LU0432979614.USD","IE00B2B36J28.USD","LU1066053197.SGD","LU0820561818.USD","IE00B1BXHZ80.USD","LU1914381329.SGD","IE000WAW04H5.SGD","VHT","BMED","LU1061106388.HKD","LBO","LU0787776722.HKD","LU1196500208.SGD","LU0345770993.USD","LU2471134952.CNY","IE00BVYPNV92.GBP","LU0058720904.USD","LU1291159041.SGD","LU1668664300.SGD","IE00BSNM7G36.USD","SGXZ80539844.SGD","LU0994945656.USD","IE00BFXG1179.USD","LU2347655156.SGD","LU1732799900.SGD","LU1267930813.SGD","AAUM","LU2896262040.SGD","LU0795875086.SGD","TRUH","LU2089984988.USD","LU2403377893.USD","LU0345769631.USD","IE00B19Z3581.USD","LU1244550577.SGD","GPZ","SG9999001176.USD","LU2430703251.USD","LU0210536198.USD","LU2213496289.HKD","LU2468319806.SGD","MEDX","LU1023059063.AUD","LU1778281490.HKD","LU2129689514.USD","LU1145028129.USD","FHLC","LU0426412945.USD","LU1551013425.SGD","LU2456880835.USD","LU1506573853.SGD","LU0124676726.USD","LU0964807845.USD","BK4184","LU2471134523.USD","LU0640476718.USD","SG9999001440.SGD","LU0234570918.USD","LU0912757837.SGD","LU0203345920.USD","LU2112291526.USD","BK4585","IE00BJT1NW94.SGD","LU1894683348.USD","LU0511384066.AUD","LU1121112475.USD","LU0689472784.USD","LU1066051225.USD","LU1983299246.USD","LU2417539215.USD","GDOC","BK4533","LU1629891620.HKD","XLV","LU2505996509.AUD","IE0000B7K699.USD","BK4559","PJP","LU0985320562.USD","IE0002270589.USD","LU2505996681.GBP","IE00BKVL7J92.USD","LU1066051498.USD","JNJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659843","title":"强生股价盘前上涨1.2%，此前有报道称阿波罗全球管理公司有意收购强生旗下骨科业务，潜在交易估值约为200亿美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659843?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 16:18","pubTimestamp":1789373891,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["JNJ","LU1032466523.USD","BK4184","APO","IE00BN8TJ469.HKD","VHT","LU1221951046.USD","IE00BDGV0183.EUR","LU0289739343.SGD","LU0320765646.SGD","LU2430703251.USD","LU1585245621.USD","BK4585","IE0009355771.USD","LU0792757196.USD","GDOC","IE000BZT7R73.USD","PRVT","LU2023250330.USD","FTXH","AAUM","LU0345769128.USD","LU0426412945.USD","IXJ","MEDX","IE000WAW04H5.SGD","TRUH","LU1066053197.SGD","LU1244550221.USD","IHE","PJP","BMED","LU0889566641.SGD","LU1430594728.SGD","JDOC","LU0882574055.USD","LU1066051225.USD","LU2896262040.SGD","LU1267930813.SGD","IE00BKVL7J92.USD","IYH","IE00B42XCP33.USD","RXL","BK4559","GPZ","LU2592432038.USD","LBO","LU0070217475.USD","FHLC","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667554366","title":"ETF异动 | 华夏恒生生科(03069)涨超4% WCLC临床数据催化密集 机构看好创新药投资机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667554366","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667554366?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 15:17","pubTimestamp":1789370250,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华夏恒生生科涨超4%。截至发稿，涨4.01%，报15.58港元，成交额6924.78万港元。本次WCLC会议上，中国新药表现亮眼，入选口头报告研究19项，小型口头报告研究45项，刷新记录。国金证券称，创新药企业扭亏节点到来，全年临床数据催化密集，叠加已BD出海管线海外临床进展顺利，看好创新药板块投资机会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4550","03069","IBBQ","BK1574","BK4585","06978","159992","MEDX","FDN","BK4588","BK1161","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655868","title":"【券商聚焦】华创证券维持翰森制药（03692）推荐评级 指创新药驱动业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655868","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667655868?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 15:01","pubTimestamp":1789369287,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华创证券发布研报指，翰森制药 2026年上半年实现总营业收入83.04亿元人民币，创新药收入约70.92亿元，占总收入比例约85.4%创历史新高；净利润42.58亿元。研发管线方面，公司创新药临床试验超70项，候选创新药超40个。华创证券指，公司创新药收入驱动业绩稳健增长，BD出海持续推进，在研管线储备丰富，看好聚焦创新和国际化的战略布局。预计2026-2028年营收分别为165.12/185.22/209.34亿元人民币，同比增长9.9%/12.2%/13.0%；归母净利润为61.10/67.78/75.09亿元人民币。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991502","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","KCE","06978","MEDX","03692","LNGR","159992","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667534816","title":"A股收评：创业板指震荡走低跌1.1%，培育钻石、创新药、MLCC概念板块涨幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2667534816","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667534816?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 15:01","pubTimestamp":1789369262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","MLCC","MEDX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667536746","title":"乐高科技、艾迪尔等35家药企涉商业贿赂，登上贵州医保基金失信企业“黑榜”","url":"https://stock-news.laohu8.com/highlight/detail?id=2667536746","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667536746?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 14:51","pubTimestamp":1789368717,"startTime":"0","endTime":"0","summary":"根据公告，对于配送企业，根据信用评价结果限制或中止配送企业在贵州省的配送资格1-5年；对于生产企业，除提醒告诫、提示风险外，限制或中止相关涉案产品或全部产品挂网、投标资格。据悉，贵州省医保基金运行服务中心给出了修复信用评级的方法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789368658648386760","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["MEDX","BK1574","RSPH","BK1583","LNGR","PTH","LGHT","AGNG","HART","09996","GDOC","BK1100","IEIH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653941","title":"创新药闯关医保","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653941","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653941?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 14:46","pubTimestamp":1789368365,"startTime":"0","endTime":"0","summary":"张力制图9月5日至8日，2026年国家基本医保药品目录现场谈判（下称“国谈”）竞价工作在北京开展，上百家国内外药企代表到场参与。本次共有124个目录外药品入围谈判竞价环节，肿瘤、罕见病、慢性病、儿童用药等社会关注度较高的创新药均在列，有望通过谈判纳入新版国家医保目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873368645.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873368645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LNGR","BK1574","159992","IBBQ","06978","BK1161","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608630","title":"港股异动 | 创新药概念股全线走高 WCLC临床数据重磅催化 机构指回调后配置价值凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608630","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667608630?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 13:39","pubTimestamp":1789364389,"startTime":"0","endTime":"0","summary":"消息面上，9月12-15日，2026年世界肺癌大会召开，多项中国创新药临床数据集中亮相，康方生物依沃西单药OS数据、B7H3ADC等成为焦点。中泰证券指出，WCLC集中披露的多项肺癌领域临床进展，进一步验证了中国创新药的临床价值和全球竞争力，或可积极把握创新药回调后的配置机会。机构普遍认为，三季度部分企业新增订单进入收入确认期，基本面有望持续改善。当前医药板块估值27倍PE，低于历史均值，回调后配置价值凸显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1574","LU0634319403.HKD","LU2476274308.USD","LU2476274720.SGD","IBBQ","01530","LU2097828805.USD","LU0348735423.USD","06978","LU0348784397.USD","LU0417516571.SGD","LU2242644610.SGD","IE00B543WZ88.USD","LU0417516738.SGD","159992","01177","09926","LU2097828557.USD","VXUS","LU0244354667.USD","01801","LU0348767384.USD","BK1161","LU1831875114.USD","LU1961090484.USD","09969","BK1593","BK4588","LU1969619763.USD","LNGR","LU0455707207.USD","IE00BZ08YR35.GBP","LU2778985437.USD","LU1188198961.HKD","LU0607220059.USD","KCAI","LU0326950275.SGD","MEDX","HK0000165453.HKD","LU0348827113.USD","LU0348825331.USD","KURE","BK1191","LU0348766576.USD","LU0561508036.HKD","LU2097828714.EUR","LU2488822045.USD","BK1521","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667637017","title":"蚂蚁集团入股医疗服务商风石健康","url":"https://stock-news.laohu8.com/highlight/detail?id=2667637017","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667637017?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 13:30","pubTimestamp":1789363802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667863208","title":"“超30家药企长期行贿”，涉案医院回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2667863208","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667863208?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 11:36","pubTimestamp":1789356960,"startTime":"0","endTime":"0","summary":"澎湃新闻首席记者 李潇潇9月13日，国家医保局发布《医疗机构涉医药购销商业贿赂案》一文提到，仅2025年下半年，河北医科大学第二医院就涉及9件司法刑事判决。在国家医保局9月13日最新披露的信息中，有超过30家医药企业长期对河北医科大学第二医院工作人员行贿。具体到河北祥恩医疗器械贸易有限公司一家，该公司为向河北医科大学第二医院销售价格虚高的医疗耗材，累计向该医院工作人员行贿2064万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-09-14/doc-iniruhxa7301443.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-14/doc-iniruhxa7301443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","IEIH","BK1574","BK1100","MDEV","09996","GDOC","LGHT","PTH","BK1583","AGNG","RSPH","MEDX","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667632818","title":"A股午评：沪指低开高走涨0.16%，MLCC概念、创新药、培育钻石板块表现活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2667632818","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667632818?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 11:31","pubTimestamp":1789356669,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MLCC","MEDX","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667634858","title":"医疗服务板块走高，万邦医药20cm涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2667634858","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667634858?lang=zh_cn&edition=fundamental","pubTime":"2026-09-14 10:31","pubTimestamp":1789353086,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":2,"totalSize":241,"code":"91000000","status":"200"}]}}